HUMA Kathleen Sebelius bought Humacyte, Inc. shares — SEC Form 4BUYHumacyte, Inc.

Kathleen Sebelius, Director at Humacyte, Inc. (HUMA), bought 50,000 shares at $1.32 ($66K) on 2025-04-08, disclosed to the SEC on 2025-04-08.

SEC EDGAR Filing

0001818382-25-000046

View on SEC EDGAR

Why this matters (generating…)

High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.

Strong73/100

Clearly above the average filing.

First-Time BuyerBuying the DipContrarian BuyMassive Holdings Increase (>100%)Opportunistic BuyUnusually Large TradeDeep Dip Buy

Trade Context

•Increased holdings by 121%
•Buying near 52-week low (+0% from bottom)
•Stock down -79% in previous 6 months

Filing Info

Filed2025-04-08

Traded2025-04-08

Accession0001818382-25-000046

SourceSEC EDGAR (Historical)

Insider

NameKathleen Sebelius

TitleDirector

PIT GradeInsiderC

Score—

View Company View Insider

Related Trades by This Insider

Ticker	Type	Filed	Value	7d Stock	Filing
HUMA	BUY	2026-05-20	$50K	—	Filing →
HUMA	SELL	2024-09-11	$28K	—

Get an email when an insider at HUMA files

Free account. Follow HUMA and up to 10 more companies.

Follow HUMA for free

HUMA Kathleen Sebelius bought Humacyte, Inc. shares — SEC Form 4BUYHumacyte, Inc.

Trade Context

Filing Info

Insider

Related Trades by This Insider

Trade Details

Outcomes